Cipla gets relief from apex court in cancer drug 'sunitinib' Law et al. News In a relief to Indian pharma major Cipla Limited, the Supreme Court Thursday stayed the order of the Delhi High Court restraining it from marketing its generic version of the Kidney and Liver cancer drug 'sunitinib' in India. A bench of Justice KS ... |
